Related Experiment Videos
Conjunctivitis in rabbits caused by enterovirus type 70 (EV70).
Investigative Ophthalmology & Visual Science
|June 1, 1986
Summary
A new rabbit model for enterovirus 70 (EV70) infection successfully mimics human conjunctivitis. This model aids in studying viral evolution, host defenses, and developing antiviral treatments for EV70.
Area of Science:
- Ophthalmology
- Virology
- Immunology
Background:
- Human enteroviral conjunctivitis is a common, contagious eye infection.
- Enterovirus 70 (EV70) is a significant cause of epidemic keratoconjunctivitis.
- Existing animal models do not fully replicate the human disease course or viral evolution.
Purpose of the Study:
- To develop and characterize a rabbit model of EV70 infection that mimics human enteroviral conjunctivitis.
- To investigate viral kinetics, host immune responses, and potential antigenic variation of EV70 in vivo.
- To establish a platform for evaluating antiviral therapies against EV70.
Main Methods:
- Topical ocular inoculation of rabbits with EV70.
- Clinical assessment of conjunctivitis signs (tearing, redness, swelling, follicles).
- Histopathological examination of ocular tissues.
- Viral load quantification (PFU/ml) in ocular fluids.
- Detection of interferon-beta (IFN-β) in tears.
- Measurement of serum antibody responses to EV70.
Main Results:
- Conjunctivitis developed within 24 hours, characterized by clinical signs and epithelial defects.
- Peak viral titers (10^3–10^6.2 PFU/ml) were observed 1-2 days post-infection, with clearance by 3-5 days.
- Antiserum neutralization suggested antigenic variation in adapted EV70 strains.
- Interferon-beta was detected in tears, and variable serum antibody responses were noted.
- Clinical, virologic, and immunologic findings closely resembled human EV70 conjunctivitis.
Conclusions:
- The rabbit EV70 model accurately replicates human enteroviral conjunctivitis.
- This model is suitable for studying EV70 antigenic variation and ocular host defenses.
- The model provides a valuable system for testing antiviral interventions against enteroviral conjunctivitis.